Financials

Discussions Technicals Seasonals

ONCSM fundamentals

Overview Statements Statistics Dividends Earnings Revenue

An in-depth look to ONCOSEM ONKOLOJIK SISTEMLER operating, investing, and financing activities

ONCSM free cash flow for Q2 24 is -3.89 M TRY. For 2023, ONCSM free cash flow was -75.41 M TRY and operating cash flow was -47.68 M TRY.

Q1 '23

Q2 '23

Q3 '23

Q4 '23

Q1 '24

Q2 '24

‪0.00‬

Cash from operating activities

Cash from investing activities

Cash from financing activities

Income statement Balance sheet Cash flow

Currency: TRY

Q1 '23

Q2 '23

Q3 '23

Q4 '23

Q1 '24

Q2 '24

TTM

YoY growth

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—